Enveric Biosciences (ENVB) Intangibles (2015 - 2024)
Enveric Biosciences' Intangibles was $42,182 in Q4 2024, down 80.0% from $210,932 a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Intangibles (2015 - 2024) Analysis & Trends
From Q1 2015 onward, Enveric Biosciences has reported Intangibles for 39 quarters.
- Intangibles has now declined for three consecutive years, with a four-year compound annual growth rate of -61.0% (FY2020 to FY2024).
- In earlier years, Intangibles was $210,932 in FY2023 (-44.4%), $379,686 in FY2022 (-94.0%), $6.38 million in FY2021 (+250.7%) and $1.82 million in FY2020.
- The Q4 2024 figure marks the lowest quarterly Intangibles in data going back to Q1 2015.
- Compared with a year earlier, Intangibles has declined for ten straight quarters, with an average decline of 73.1% over the last eight quarters.
- The best year-over-year quarter for Intangibles over five years was Q4 2021 (growth of 250.7%); the worst was Q3 2023 (a decline of 96.0%).
- Per Business Quant data, ENVB's Intangibles in the three quarters before Q4 2024 was $84,368 (Q3 2024), $126,556 (Q2 2024) and $168,744 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 42,182.00 |
| Sep 30, 2024 | 84,368.00 |
| Jun 30, 2024 | 126,556.00 |
| Mar 31, 2024 | 168,744.00 |
| Dec 31, 2023 | 210,932.00 |
| Sep 30, 2023 | 253,120.00 |
| Jun 30, 2023 | 295,311.00 |
| Mar 31, 2023 | 337,498.00 |
| Dec 31, 2022 | 379,686.00 |
| Sep 30, 2022 | 6.32 Mn |
| Jun 30, 2022 | 6.74 Mn |
| Mar 31, 2022 | 6.97 Mn |
| Dec 31, 2021 | 6.38 Mn |
| Sep 30, 2021 | 38.27 Mn |
| Jun 30, 2021 | 2.19 Mn |
| Mar 31, 2021 | 2.36 Mn |
| Dec 31, 2020 | 1.82 Mn |
| Sep 30, 2020 | 1.95 Mn |
| Jun 30, 2020 | 2.49 Mn |
| Mar 31, 2020 | 3.04 Mn |
API Access
Enveric Biosciences Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();